Nestle
NESN.SW Mega CapConsumer Defensive · Packaged Foods
Updated: Jul 5, 2026, 22:19 UTC
Price Chart
Key Metrics
Valuation Analysis
About the Company
Nestlé S.A., together with its subsidiaries, manufactures and distributes food and beverage, and nutritional science products in the United States, Brazil, Mexico, Greater China, the Philippines, India, the United Kingdom, France, Germany, Switzerland, and internationally. The company offers cereals, chocolate and confectionery, coffee, culinary, chilled and frozen food, dairy, drinks, food service, ice cream, nutrition and health, petcare, water, plant-based portfolio, and recipe products. It sells its products under the Nesquik Cereal, Fitness, Cheerios, Lion Cereals, Cini Minis, KitKat Cereal, Chocapic, Koko Krunch, Shreddies, Shredded Wheat Original, Corn Flakes, Trix Cereal, Aero, Baci Perugina, KitKat, Milkybar, Smarties, Cailler, Quality Street, Garoto, Nestlé Toll House, Munch, Dam
Nestle Stock at a Glance
Nestle (NESN.SW) is currently trading at CHF 84.55 with a market capitalization of $217.5B. The trailing P/E ratio stands at 24.09x, with a forward P/E of 17.91x. The 52-week range spans from CHF 69.90 to CHF 85.06; the current price is 0.6% below the yearly high. Year-over-year revenue growth stands at -2.2%. The net profit margin stands at 10.05%.
💰 Dividend
Nestle pays an annual dividend of CHF 3.10 per share, representing a yield of 3.67%. The payout ratio stands at 86.89%. The elevated payout ratio reflects a mature dividend policy.
📊 Analyst Rating
22 analysts rate Nestle (NESN.SW) on consensus: Buy. The average price target is CHF 88.15, implying +4.25% from the current price. Analyst price targets range from CHF 69.00 to CHF 102.00.
Nestle: The Investment Case in Detail
Nestle (NESN.SW) operates in the Consumer Defensive — specifically Packaged Foods — and is headquartered in Switzerland. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.
The Bull Case
Return on equity of 26.53% places management among the most capital-efficient operators in the public market — every euro of shareholder capital is working hard.
The Bear Case
Revenue is contracting at -2.2% year-over-year — until that trend reverses, valuation is exposed to further downgrades.
What to Watch Next
- The forward P/E of 17.91x is meaningfully below the trailing 24.09x — analysts expect earnings to step up; the next earnings release is the test.
- The share is trading at 96.6% of its 52-week range — a break above the recent high opens technical upside, a failure here often invites profit-taking.
Investment Thesis: Strengths & Weaknesses
- High return on equity (26.53% ROE)
- Analyst consensus: Buy
- Solid dividend yield of 3.67%
- Positive free cash flow
- –Revenue shrinking (-2.2% YoY)
- –High leverage (D/E 175)
- –Price near 52-week high — limited upside cushion
Technical Snapshot
Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).
Risk Profile
The data points to relatively defensive market behavior, higher leverage relative to equity.
Trading Data
💵 Dividend Info
Related Stocks in the Same Sector
Nestlé 2026: The Sleeping Giant Awakens — Freixe Reset in the Consumer Goods Storm
The Real Story
Nestlé in 2026 is in its biggest strategic transition phase since the invention of Nespresso in 1986. The new CEO Laurent Freixe (took office in August 2024 after the surprising departure of Mark Schneider) announced a complete valuation reset in November 2024: organic growth target reduced from 4-6% to 3-4%, EBITDA margin ambition from 17.5%+ relativized to 'mid-teens'. The stock fell from CHF 96 to current CHF 76.88 — the lowest level since the 2020 pandemic.
The actual 2026 investment setup has three components: First, the restructuring of weak portfolio parts is underway (DiGiorno pizza divestiture, mineral water segment review, possible spin-off of the 20.1% L'Oréal stake). Second, Freixe focuses radically on the most profitable business segment: Coffee (Nespresso, Nescafé, Starbucks license — together 28% of revenue, 40% of profit). Third, the new marketing investment program of $2B additional in 2026 — deliberately margin-burdening in the short term but category-strengthening long term.
The GLP-1 wave hits Nestlé too: throat lozenges, Maggi packaged soups, and sweet baked goods show -3 to -5% volume trends in the US. But Nestlé's diversification advantage is large: pet food (Purina, 18% revenue, high margin, GLP-1 immune), coffee (no snack substitute), and Nutritional Health Science (positive from GLP-1 as co-therapy).
What Smart Money Thinks
Nestlé is classically held by European income investors — not by US smart-money activists. Capital Group holds 2.8% outstanding, BlackRock 4.2%, Norges Bank Investment Management (Norway sovereign fund) 3.1%. All passive to quasi-passive holders.
Notable: Third Point (Dan Loeb) built a 0.3% activist position in Q4/2024 — directly after the Freixe reset. Loeb's thesis per January 2025 investor letter: Nestlé should spin off the L'Oréal stake and distribute 70% of proceeds as a special dividend — value unlock $25-30B. Loeb was previously successful at Nestlé in 2017-2019 (coffee strategy pivot pushed through).
Insider: CEO Freixe signaled his first share purchase program in February 2026 — CHF 5M. Symbolic but important: first time since taking office that top management risks personal capital. Family-foundation sales (Nestlé family foundations) were absent in Q1/2026.
Explore the BMI Smart-Money Tracker →
📈 The 3 Real Bull Points
Nestlé holds 20.1% of L'Oréal — market value CHF 28B. This stake generates only 3% dividend yield versus Nestlé's own reinvestment opportunities (8-12% ROIC). Activist pressure (Loeb) and CEO turnover open the window for monetization — block sale or spin-off to shareholders. If proceeds for special dividend or buyback: 12-15% upside lever on the stock.
Nespresso plus Nescafé plus Starbucks license together 28% of revenue, 40% of profit, organic growth 6-8% despite consumer weakness. Coffee is GLP-1 immune (no calorie substitutes), premium-trend stable (consumers drink less but pricier), and Nespresso has a structural subscription advantage. Freixe has already announced $1.2B additional marketing in Coffee alone in 2026.
Nestlé has raised its dividend annually since 1995 — one of the longest aristocrat series globally. Current yield 4.03% sits in the 92nd percentile of the past 20 years, comparable troughs only in 2009 and 2020. With stable CHF dividend and mean reversion to 3.2% yield, that alone implies +20% price upside from yield compression.
📉 The 3 Real Bear Points
Nestlé's payout ratio is at 87% — highest level since 2002. With -24% EPS growth in 2025 and only -3 to 0% recovery in 2026, the payout ratio in 2026 will likely exceed 100%. Management would have to either abandon the aristocrat reputation (cut dividend growth rate to 1-2%) or pause buybacks ($5B per year currently). Both would disillusion smart-money holders.
Nestlé confectionery brands (KitKat, Crunch, Aero, Smarties) and sweet baked goods show initial -3 to -5% volume trends in the US and UK. With 30M projected US GLP-1 users by 2030, structural -2% to -4% volume hit on 25-30% of the Nestlé portfolio is realistic. Nestlé's response (better-for-you lines) is slower and lower-margin than Mars and Hershey.
Forward P/E 16.4 sounds cheap, but with -24% EPS 2025 and 0-3% in 2026, PEG ratio is 2.14 — comparable to Unilever (PEG 2.3), but more expensive than Procter & Gamble (1.8) or Coca-Cola (1.9). For a conglomerate going through its worst phase since 2002, the stock is not the bargain its headline valuation suggests.
Valuation in Context
Nestlé trades at forward P/E 16.4 (10y median 21) and EV/EBITDA 12.8 (10y median 15.8) — both significantly below own historical valuation levels. Three models: (1) Mean reversion: at P/E 19 and 2027 EPS consensus CHF 5.20 = fair value CHF 99 (+29%). (2) SOTP model: Coffee segment (40% profit) at 22x = CHF 110B, pet food (18% profit) at 18x = CHF 35B, health science at 25x = CHF 25B, rest at 15x = CHF 60B, plus L'Oréal stake CHF 28B — total CHF 258B vs current market cap CHF 198B = 30% upside. (3) Dividend discount: at 4% yield requirement and 2% growth: fair value CHF 82 (+7%). Asymmetry is positive but not extreme.
🗓️ Next 3 Catalyst Dates
- June 2026: Nestlé Capital Markets Day in Lausanne — new 2027-2030 strategy targets, possible L'Oréal stake roadmap announcement
- July 2026: H1 2026 earnings with first full quarter after the marketing investment program — volume indicator for strategy validation
- October 2026: Possible L'Oréal stake reduction via accelerated block sale — value-realization trigger
💬 Daniel's Take
Nestlé in 2026 is the classic 'defensive value catches value' setup: 4% dividend, 51-year aristocrat, defensive business model, but under strategic pressure from GLP-1 and a management reset. My take: this is the kind of stock you buy to park money — not when you chase performance. For a $50K-200K portfolio, I would hold Nestlé as a 3-4% income sleeve, comparable to Coca-Cola or PepsiCo. For international investors: 35% Swiss withholding tax, 15% creditable via tax treaty — net 2.6% yield. Not the most attractive income train. Price target: CHF 88-95 in 18-24 months, if L'Oréal stake monetization comes or coffee growth accelerates. On loss of aristocrat reputation (dividend cut) I would sell — stop-loss CHF 68.
Sources (3)
Disclaimer: This article is not investment advice. Investing in stocks carries risks, including total loss.
More Consumer Defensive stocks
Top peers in the same sector — ranked by market cap.
Where can I buy Nestle?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
📊 Prefer a fund over a single stock? Compare ETFs:
Live Market Data
Real-time chart, financials, earnings, analysts, insider trades, events & news